Dr John D Diekman

KANDO id: 19991

Bio

Dr Diekman is a founder and Managing Partner of 5AM Ventures. Prior to founding 5AM, Dr Diekman was a founder and Managing Director of Bay City Capital, a life sciences investment firm. Previously, Dr Diekman was Chairman and CEO of Affymetrix Inc where he still serves as a Director. Dr Diekman currently serves as Board Chairman of Ambrx and Envoy as well as on the Boards of Directors of Igenica, Ingenuity Systems, Marcadia, PhaseRx, Phenomix and Wildcat Discovery. He is a Special Advisor to the Singapore Economic Development Board. He is a Trustee of Princeton University and is also former Trustee of The California Institute of Technology and The Scripps Research Institute, where he served as Chairman. Dr Diekman holds a BA in Chemistry from Princeton University and a PhD in Chemistry from Stanford University.

Education